Licensee in Thailand: Stem Cells 21. Licensee in Australia: Cell-Innovations. Licensee in Canada: Regenastem. Haven't they been partners with SVFC for over 2 years now? Where are the 'milions' in purported revenues from these international partners? 2011, 2012 and 2013 total revenues for SVFC (according to their own financial statements): ZERO!!
Let me pull back the proverbial shades a little bit. The partnership with Stem Cells 21 was terminated and SVFC had to acrrue up to $150,000 in license fee liabilities. So, the horse never got out of the gate in Thailand. But what about the other two, in Australia and Canada? Clue: Southern District in New York.